Adiponectin, with its insulin-sensitizing, antiatherogenic, antiapoptotic, and antiinflammatory effects, may play a role in future therapies for obesity, type 2 diabetes, and atherosclerosis [4]. This evidence concerns the gene INS and type 2 diabetes mellitus.